New hope for stubborn joint infections: adding rifampin to standard care
NCT ID NCT07313215
First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looks at whether adding the antibiotic rifampin to usual treatment can better clear staphylococcal infections in artificial joints. About 428 adults who had joint replacement surgery and developed an infection will take part. After surgery to clean the joint, they receive either standard antibiotics alone or standard antibiotics plus rifampin for 3 months. The goal is to see which group has fewer infections over 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPROSTHETIC JOINT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.